APA (7th ed.) Citation

He, X., Hu, X., Ma, X., Su, H., Ying, L., Peng, J., . . . Jia, W. (2017). Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus. Cardiovascular diabetology, 16(1), 77-8. https://doi.org/10.1186/s12933-017-0559-x

Chicago Style (17th ed.) Citation

He, Xingxing, et al. "Elevated Serum Fibroblast Growth Factor 23 Levels as an Indicator of Lower Extremity Atherosclerotic Disease in Chinese Patients with Type 2 Diabetes Mellitus." Cardiovascular Diabetology 16, no. 1 (2017): 77-8. https://doi.org/10.1186/s12933-017-0559-x.

MLA (9th ed.) Citation

He, Xingxing, et al. "Elevated Serum Fibroblast Growth Factor 23 Levels as an Indicator of Lower Extremity Atherosclerotic Disease in Chinese Patients with Type 2 Diabetes Mellitus." Cardiovascular Diabetology, vol. 16, no. 1, 2017, pp. 77-8, https://doi.org/10.1186/s12933-017-0559-x.